We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.09%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$269B
AUM Growth
+$11B
(+4.3%)
Cap. Flow
-$7.32B
Cap. Flow
% of AUM
-2.72%
Top 10 Holdings %
Top 10 Hldgs %
22.8%
Holding
3,195
New
25
Increased
1,065
Reduced
1,860
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$425M |
| 3 |
Boeing
BA
|
+$396M |
| 4 |
Linde
LIN
|
+$381M |
| 5 |
ExxonMobil
XOM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.4B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$323M |
| 3 |
Accenture
ACN
|
+$264M |
| 4 |
Microsoft
MSFT
|
+$258M |
| 5 |
Union Pacific
UNP
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOCS
1576
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $8.33M | ﹤0.01% |
160,573
-22,901
| -12% | -$1.1M |
|
1577
Denali Therapeutics
DNLI
$3.97B
| $8.31M | ﹤0.01% |
360,636
-15,111
| -4% | -$416K |
|
1578
V2X
VVX
$2.65B
| $8.3M | ﹤0.01% |
209,060
+14,978
| +8% | +$640K |
|
1579
Agios Pharmaceuticals
AGIO
$1.93B
| $8.3M | ﹤0.01% |
361,192
-9,536
| -3% | -$253K |
|
1580
Tencent Music
TME
$15.6B
| $8.29M | ﹤0.01% |
1,001,217
-108,880
| -10% | -$891K |
|
|
ARCH
1581
DELISTED
Arch Resources, Inc.
ARCH
| $8.25M | ﹤0.01% |
62,773
-734
| -1% | -$106K |
|
|
CFLT
1582
DELISTED
Confluent
CFLT
| $8.24M | ﹤0.01% |
342,359
-10,700
| -3% | -$248K |
|
1583
CONMED
CNMD
$1.47B
| $8.21M | ﹤0.01% |
79,091
-1,568
| -2% | -$152K |
|
|
WSR
1584
DELISTED
Whitestone REIT
WSR
| $8.2M | ﹤0.01% |
891,235
+139,542
| +19% | +$1.35M |
|
1585
Unifirst Corp
UNF
$5.25B
| $8.18M | ﹤0.01% |
46,398
-4,870
| -9% | -$950K |
|
1586
Clarivate
CLVT
$1.16B
| $8.17M | ﹤0.01% |
870,426
-58,607
| -6% | -$604K |
|
1587
Liberty Global Class A
LBTYA
$3.6B
| $8.17M | ﹤0.01% |
418,980
-9,072
| -2% | -$184K |
|
1588
Cactus
WHD
$5.44B
| $8.17M | ﹤0.01% |
198,120
-1,574
| -0.8% | -$76K |
|
1589
ADT
ADT
$5.58B
| $8.17M | ﹤0.01% |
1,129,598
-8,932
| -0.8% | -$72.8K |
|
1590
Atlantic Union Bankshares
AUB
$5.97B
| $8.15M | ﹤0.01% |
232,688
-43,410
| -16% | -$1.61M |
|
|
PRVB
1591
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $8.13M | ﹤0.01% |
337,165
-74,141
| -18% | -$930K |
|
1592
Immunovant
IMVT
$8.25B
| $8.1M | ﹤0.01% |
522,396
+198,478
| +61% | +$3.44M |
|
|
BPMC
1593
DELISTED
Blueprint Medicines
BPMC
| $8.1M | ﹤0.01% |
179,950
-14,647
| -8% | -$660K |
|
1594
Kura Oncology
KURA
$850M
| $8.07M | ﹤0.01% |
660,101
-35,560
| -5% | -$444K |
|
1595
Trustmark
TRMK
$2.75B
| $8.07M | ﹤0.01% |
326,623
+42,338
| +15% | +$1.25M |
|
1596
Arcus Biosciences
RCUS
$3.64B
| $8.05M | ﹤0.01% |
441,241
+298,925
| +210% | +$5.71M |
|
1597
Certara
CERT
$1.25B
| $8.02M | ﹤0.01% |
332,537
+25,900
| +8% | +$512K |
|
1598
Digi International
DGII
$3.1B
| $8M | ﹤0.01% |
237,481
+13,357
| +6% | +$456K |
|
1599
BOK Financial
BOKF
$8.74B
| $7.98M | ﹤0.01% |
94,499
+3,882
| +4% | +$379K |
|
1600
BancFirst
BANF
$3.8B
| $7.93M | ﹤0.01% |
95,393
+7,069
| +8% | +$609K |
|
Similar funds
VFT
Nuveen's Q1 2023 Portfolio in Review
As of Q1 2023, Nuveen held 3,195 positions worth $269B, up 4.3% from $258B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.3%. Nuveen opened 25 new positions and exited 81, leaving the 3,195-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q1 2023 buy was GE HealthCare: 1,240,905 shares worth $102M.
- Nuveen added most to Meta Platforms (Facebook) in Q1 2023, an estimated $1.08B increase.
- Nuveen's biggest Q1 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.4B.
- Nuveen fully exited SVB Financial Group in Q1 2023, selling an estimated $51.6M.
- Nuveen's ten largest holdings make up 23% of its $269B portfolio in Q1 2023.
- Nuveen opened 25 new positions and closed 81 in Q1 2023.
- Nuveen's portfolio value rose 4.3% quarter-over-quarter to $269B.
Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.